Peptide & Hormone Therapies for Health Performance & Longevity | Dr. Craig Koniver

Dr. Craig Koniver on the Clinical Reality of Peptide Therapy

Dr. Craig Koniver is not a podcast doctor who read a few studies. He is board-certified, trained at Brown and Thomas Jefferson, and has been prescribing peptides to patients for years. That clinical experience makes this conversation with Huberman different from the typical peptide discussion. This is what peptide therapy looks like when a physician is actually monitoring bloodwork, adjusting doses, and tracking outcomes over time.

GLP-1 Analogs Through a Clinician's Lens

Koniver has prescribed GLP-1 medications to patients and seen the results firsthand. He talks about semaglutide and tirzepatide not as weight loss miracles but as tools with specific use cases. For some patients, especially those with significant metabolic dysfunction, these drugs can reset the trajectory. But Koniver is clear that the drug alone is not the answer. Without addressing diet quality, sleep, and movement patterns, you are just putting a band-aid on a broken system.

He gets into the nuances of dosing that most content creators skip entirely. Starting low, titrating slowly, watching for GI side effects, and adjusting based on how the patient responds. This is not a one-size-fits-all protocol, and Koniver pushes back on the idea that you can just copy someone else's dose from a Reddit thread.

BPC-157: From Theory to Patient Outcomes

The BPC-157 segment is particularly interesting because Koniver talks about what he has actually seen in practice. He uses BPC-157 primarily for patients dealing with chronic inflammation, gut issues, and soft tissue injuries. His clinical observation is that many patients report noticeable improvement within one to two weeks of starting subcutaneous injections.

But he also flags something important: not every patient responds. Some people get minimal benefit, and he is honest that we do not fully understand why. Genetics, the specific nature of the injury, and individual inflammatory profiles all likely play a role. This kind of nuance gets lost in the online hype machine where every peptide testimonial sounds like a miracle.

Growth Hormone Peptides and Sleep Architecture

Koniver connects growth hormone peptides directly to sleep quality, specifically REM sleep. Peptides like Ipamorelin and CJC-1295 are typically taken before bed, and the resulting growth hormone pulse coincides with your natural nighttime release pattern. Patients often report that their sleep improves before they notice body composition changes.

This is a practical insight that matters. If you are sleeping terribly, your recovery is compromised, your cortisol is elevated, and your ability to lose fat or build muscle is diminished. Improving sleep architecture through targeted GH release can have cascading downstream effects that go way beyond what you see on the scale.

Testosterone, NAD, and the Broader Protocol

Koniver practices integrative medicine, which means he is rarely using just one intervention at a time. He discusses testosterone replacement therapy as a foundational piece for men with clinically low levels. He talks about NAD+ supplementation and its role in cellular energy production. He even gets into methylene blue, a compound that has gained traction in longevity circles for its effects on mitochondrial function.

The conversation around stem cells is more cautious. Koniver acknowledges the potential but emphasizes that the regulatory environment is complicated and the evidence is still early-stage for many applications. He is not dismissive, but he is not making promises either.

Cognitive Function and the Peptide Stack

One of the more interesting threads is Koniver's approach to cognitive optimization. He describes using certain peptides alongside lifestyle modifications to help patients with brain fog, poor focus, and age-related cognitive decline. The mechanisms are varied: some peptides increase blood flow to the brain, others modulate neurotransmitter activity, and improved sleep from GH peptides indirectly supports cognitive function.

This is where the conversation moves beyond the typical "get shredded" peptide narrative and into territory that matters for a broader audience. Cognitive decline is something almost everyone will face, and the idea that targeted peptide therapy might help preserve function is worth paying attention to, even if we need more controlled human trials.

How Koniver Actually Works With Patients

Koniver runs Koniver Wellness in Charleston, South Carolina, and his clinic model is worth understanding because it is different from a standard doctor's office. Patients typically start with extensive bloodwork, far more panels than a regular annual physical would include. He tests inflammatory markers, hormone levels, micronutrient status, metabolic markers, and sometimes genetic panels. That baseline data drives everything that follows.

From there, he builds individualized protocols. One patient might get BPC-157 for a nagging tendon issue alongside testosterone replacement. Another might get NAD+ infusions and Ipamorelin for sleep and energy without any tissue repair peptides at all. The point he makes to Huberman is that cookie-cutter peptide protocols miss the mark. Two people with the same complaint can have completely different underlying biology, and the treatment should reflect that.

He also talks about follow-up cadence. Patients get repeat bloodwork at regular intervals, usually every 6 to 12 weeks during active treatment. If markers move in the wrong direction or the patient is not responding, he adjusts. This iterative approach is what separates clinical peptide use from the self-experimentation that happens online, where people pick a dose from a forum and never adjust.

NAD+ and Methylene Blue: The Deep Dive

Koniver uses both IV NAD+ infusions and oral precursors (NMN and NR) depending on the patient and the goal. IV infusions deliver a much larger dose directly into the bloodstream, and patients often report immediate effects on energy and mental clarity. But IV infusions are expensive and time-consuming, so oral precursors serve as maintenance between infusions.

Methylene blue gets a surprisingly detailed segment. Koniver uses pharmaceutical-grade methylene blue at low doses for its effects on mitochondrial function. It acts as an alternative electron carrier in the mitochondrial electron transport chain, improving energy production in cells where the normal pathway is impaired. Patients report better focus and energy, particularly those with brain fog that has not responded to other interventions. Dosing matters: too much causes serotonin-related side effects, so this is not something to self-dose.

What to Expect at Your First Peptide Clinic Visit

If Koniver's approach sounds appealing and you are considering working with a peptide-prescribing physician, it helps to know what the process actually looks like. Based on what Koniver describes and what similar clinics offer, here is a realistic preview.

The first step is extensive bloodwork. Expect to get far more panels drawn than a standard annual physical. A typical peptide clinic will test complete metabolic panel, complete blood count, fasting insulin, HbA1c, lipid panel, thyroid panel (TSH, free T3, free T4), total and free testosterone (for both men and women), estradiol, DHEA-S, IGF-1, inflammatory markers (hs-CRP, homocysteine), vitamin D, ferritin, and sometimes a full micronutrient panel. This baseline costs $300-800 out of pocket if insurance does not cover it, or sometimes more through boutique lab services.

Your first physician consultation will review this bloodwork and your health history, goals, and concerns. A good peptide physician will not simply prescribe whatever you ask for. They will use the data to build a rationale for each intervention. If your IGF-1 is already in a healthy range, growth hormone peptides might not be the priority. If your inflammatory markers are elevated, BPC-157 or lifestyle changes might come first.

Once a protocol is established, you will receive the peptides from a compounding pharmacy, typically shipped to your home with instructions for reconstitution, storage, and injection technique. Most peptide clinics provide video guides or nurse consultations for the injection process. Follow-up bloodwork happens every 6-12 weeks during active treatment, with protocol adjustments based on results. The total cost for a peptide clinic program typically runs $200-500 per month including physician visits, labs, and the peptides themselves, though it varies widely by clinic and protocol complexity.

Koniver vs. the Self-Experimentation Approach

The elephant in the room during this entire episode is that many people using peptides are not working with a physician like Koniver. They are buying from research chemical companies, dosing based on forum advice, and skipping bloodwork entirely. Koniver does not spend much time criticizing this approach directly, but the contrast between what he describes and what happens in online peptide communities is stark.

Here is what the self-experimentation approach misses. Without baseline bloodwork, you do not know whether the peptide is actually changing anything measurable. You feel better? That might be the peptide, or it might be placebo, or it might be something else you changed around the same time. Without follow-up labs, you do not catch early warning signs. Growth hormone peptides can affect insulin sensitivity, and if you are not testing fasting insulin and glucose periodically, you will not know until the problem is advanced. Without physician oversight, you have no one to adjust your protocol when something is not working or when side effects emerge.

The Huberman peptide therapeutics episode (covered on FormBlends) makes similar points about sourcing and quality. But Koniver adds the clinical dimension. It is one thing to buy a quality product. It is another to use it intelligently within a monitored protocol. The two Brigham Buhler JRE episodes focus more on the access and regulatory side, while Koniver gives you the clinical practice side. Together, they paint a complete picture of what responsible peptide use looks like versus the shortcut version that carries real risks.

The Sleep and Growth Hormone Connection in Practice

The segment on GH peptides and sleep quality deserves more attention because it has immediate practical implications. Koniver mentions that patients often report improved sleep before they notice body composition changes. This is more than a side benefit. It is a cascade trigger.

Poor sleep elevates cortisol. Elevated cortisol promotes visceral fat storage, impairs immune function, and reduces insulin sensitivity. It also blocks the natural nighttime growth hormone pulse that is responsible for tissue repair and recovery. When GH peptides like Ipamorelin improve sleep architecture (specifically increasing slow-wave sleep, which is when the largest GH pulses occur), the downstream effects spread across multiple systems.

Patients who start sleeping better often report reduced cravings, better workout recovery, improved mood, and clearer thinking within the first two weeks. These are not directly caused by the growth hormone itself. They are caused by the improved sleep that the GH pulse supports. This is why Koniver often starts patients on GH peptides before introducing other interventions. Fix the sleep first, and many other problems improve on their own.

For people on GLP-1 medications who are struggling with fatigue or poor recovery, this connection is worth discussing with your physician. GLP-1 drugs do not directly affect sleep, but the caloric restriction they cause can impair sleep quality in some patients. A GH peptide protocol timed before bed might address that gap without conflicting with the GLP-1 medication.

The Value of a Real Clinician's Perspective

What makes this episode stand out is simple: Koniver has skin in the game. He prescribes these therapies, monitors patients, and deals with the consequences when something does not work as expected. That accountability forces a level of honesty that you will not get from someone who just sells peptides online. If you are considering peptide therapy, this episode gives you a realistic picture of what working with an informed physician actually looks like.